Stay updated on ECHO-204 Clinical Trial: Epacadostat + Nivolumab
Sign up to get notified when there's something new on the ECHO-204 Clinical Trial: Epacadostat + Nivolumab page.

Latest updates to the ECHO-204 Clinical Trial: Epacadostat + Nivolumab page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2; there are no changes to study content, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check19 days agoChange DetectedThe page now shows Revision: v3.4.1, replacing the previous Revision: v3.4.0.SummaryDifference0.0%

- Check33 days agoChange DetectedThe page now includes a glossary toggle (Show glossary / Hide glossary) and a new 'Last Update Submitted that Met QC Criteria' label in the Study Record Dates. The footer shows 'Revision: v3.4.0' and capitalization tweaks to 'No FEAR Act Data'.SummaryDifference0.2%

- Check41 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4; no substantive changes to the study content, eligibility criteria, or results are visible in the screenshot.SummaryDifference0.0%

- Check69 days agoChange DetectedThe study locations were updated to add new U.S. sites across multiple states, and older listed locations were removed. A page revision tag accompanies this update.SummaryDifference1%

- Check90 days agoChange DetectedRevision label updated from v3.2.0 to v3.3.2 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to ECHO-204 Clinical Trial: Epacadostat + Nivolumab
Enter your email address, and we'll notify you when there's something new on the ECHO-204 Clinical Trial: Epacadostat + Nivolumab page.